Using artificial intelligence, MIT researchers can design nanoparticles that more efficiently deliver RNA vaccines and other types of RNA therapies. This approach could dramatically speed the process of developing new RNA vaccines, as well as RNA therapies that could be used to treat obesity, diabetes, and other metabolic disorders.